Interleukin 2 Receptor-directed Antibody Interactions
- Interleukin 2 Receptor-directed Antibody Interactions
- Accession Number
- Not Available
Drug Drug Description Daclizumab A monoclonal anti-CD25 antibody that blocks the interleukin-2 receptor which is used to treat relapsing forms of multiple sclerosis. Basiliximab A monoclonal anti-C25 antibody (interleukin-2 receptor alpha subunit) used as immunosuppressive therapy in kidney transplant patients.
- Drugs & Drug Targets